Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2002
09/11/2002CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase
09/11/2002CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them
09/10/2002US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c
09/10/2002US6448271 Substituted benzimidazoles and their use as parp inhibitors
09/10/2002US6448268 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists
09/10/2002US6448265 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
09/10/2002US6448257 Tricyclic carboxamides contain a piperazine or piperidine moiety; antiinflammatory agents; heart and kidney conditions
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002US6448203 Substituted aryluracils
09/10/2002CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors
09/10/2002CA2042857C Curable bismaleide systems
09/09/2002CA2375303A1 Herbicidal 2-alkynyl-pyri(mi)dines
09/06/2002WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068414A2 Analogs of thalidomide as potential angiogenesis inhibitors
09/06/2002WO2002068413A1 Pyrazolyl pyrimidines
09/06/2002WO2002068412A1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
09/06/2002WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
09/06/2002WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
09/06/2002WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002WO2002068057A1 Barbiturates as integrin antagonists and their use for treating inflammatory diseases
09/06/2002WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002WO2002048115A3 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
09/06/2002WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors
09/06/2002WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/06/2002CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/05/2002US20020123629 Benzothiadiazoles and derivatives
09/05/2002US20020123513 Administering indole-2-carboxylic amide derivatives of given formula
09/05/2002US20020123491 Selective neurokinin antagonists
09/05/2002US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine
09/05/2002DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases
09/05/2002DE10108480A1 Pyrazolylpyrimidine Pyrazolylpyrimidine
09/05/2002CA2337109A1 Herbicidal 2-pyrazolyl-6-aryloxypri(mi)dines
09/04/2002EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
09/04/2002EP1235806A1 Novel 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives
09/04/2002EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
09/04/2002EP1068184B1 N-aryloxyethylamine derivatives for the treatment of depression
09/04/2002EP0966476B1 Quinazolinone compounds
09/04/2002EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
09/04/2002EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds
09/04/2002CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/04/2002CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/03/2002US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators
09/03/2002US6444811 Central nervous system disorders; cardiovascular disorders
09/03/2002US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents
09/03/2002US6444687 Eating disorders and diabetes
09/03/2002US6444671 Cyclic AMP-specific phosphodiesterase inhibitors
09/03/2002US6444615 Compounds effective as preemergent and postemergent herbicides
09/03/2002CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
09/03/2002CA2225626C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
08/2002
08/29/2002WO2002066679A1 Intercalator suitable for electrochemical detection of double strand dnas and a process for preparing thereof
08/29/2002WO2002066465A1 Water-soluble triazole fungicide
08/29/2002WO2002066463A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
08/29/2002WO2002066462A1 Pyrazole derivatives against tgf overexpression
08/29/2002WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors
08/29/2002WO2002066460A1 Chemical compounds
08/29/2002WO2002066459A1 Indole derivatives and their use as gnrh antagonists
08/29/2002WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066443A2 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
08/29/2002WO2002066440A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists
08/29/2002WO2001081336A8 Process for the synthesis of a known tetrazol derivative
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them
08/29/2002US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies
08/29/2002US20020119992 Anticoagulants
08/29/2002US20020119988 Modulators of TNF-alpha signaling
08/29/2002US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002US20020119963 Fertility; antidiabetic agents
08/29/2002US20020119962 Novel urea compounds, compositions and methods of use and preparation
08/29/2002US20020119956 Using thalidomine
08/29/2002US20020117396 N-((4-(3-ferrocenecarboxamidopropyl)piperazinyl)-propyl)-1, 8-naphthalene imide
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/28/2002EP1233960A2 Polymorphic salt of an anti-migraine drug
08/28/2002EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
08/28/2002EP1233949A2 5-substituted arylpyrimidines
08/28/2002EP1233945A1 Heterocyclic ketone and thioester compounds and uses
08/28/2002EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands
08/28/2002EP1233769A1 Novel compounds
08/28/2002EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
08/28/2002EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
08/28/2002EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators
08/28/2002CN1365972A Indole derivatives and its anticancer usage
08/28/2002CN1089763C Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
08/28/2002CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441192 Adding acid chloride and alkyl or aryl magnesium halide separately and simultaneously to a stirred solution of an indole such that the two reagents do not come into immediate contact; synchronised rates of molar addition
08/27/2002US6441175 Useful in treating various neuropsychological disorders including, schizophrenia, dementia, depression, anxiety, parkinson-like motor disorders and motion disorders
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6441018 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity